Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Marker for Asthma Identified at Oxford

11.02.2003


Researchers at Oxford University’s Wellcome Trust Centre for Human Genetics have located a variant form of a polynucleotide sequence in the MHC region of chromosome 6p and identified its association with an increased secretion of TNF. Potential applications for this discovery include the diagnosis of asthma in patients, or a predisposition to asthma, and a patients’ suitability for treatment with anti-TNF therapy.



Asthma is a disease in which the airways become inflamed leading to blockage and narrowing, with resultant symptoms including wheezing, coughing, shortness of breath and tightening of the chest. Asthma sufferers can be of any race, age or sex, and over 17 million people in the United States alone suffer from the disease.

Most asthma is initiated by an IgE mediated allergy (atopy) to inhaled environmental allergens, including pollen, air pollutants and irritants. The susceptibility to asthma is strongly familial, and is due to both genetic and environmental factors. The identification of other genetic factors will lead to further understanding of susceptibility to asthma and an ability to develop a pharmacogenomic approach to treatment, new therapeutic approaches to treat sub-groups of patients who will benefit most from them. Tumour necrosis factor (TNF) is a potent pro-inflammatory cytokine that is found in increased concentrations in asthmatic airways and in lavage fluid from asthmatic lungs.


The Oxford research team has found that unusual genetic variants in or linked to the TNF? gene are predictive of asthma and inhaled or oral steroid usage in asthmatic individuals. This exciting new technology may be used as a diagnostic tool, useful to predict the clinical course of disease or the response to particular treatments, as well as helping to develop new therapeutic strategies.

Isis Innovation, Oxford University’s technology transfer company, has filed a patent application (US 09/058,165, 20010007741) and is actively seeking licensees to develop and commercialise this technology.

Jennifer Johnson | alfa
Further information:
http://www.isis-innovation.com/licensing/146.html

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>